Sarah Missel, Ph.D.

Vice President Development Lead Bispecifics TCER®

Sarah Missel joined Immatics in 2011, where she started as Scientist in Immunology and subsequently held several positions leading cross-functional teams in various internal and collaboration projects. Besides her tasks in Translational Development, she was responsible for R&D strategy and communications. Her current work as Development Lead, is focused on development and oversight of Immatics’ clinical and preclinical TCER® pipeline and portfolio. This includes the translation of preclinical projects into early phase clinical trials as well as leadership for clinical TCER® stage programs.

Sarah studied Pharmacy at the University of Würzburg and gathered some experience in clinical research at GSK. Her academic research at the Institute of Virology of TU/Helmholtz Centre Munich was focused on therapeutic HIV vaccines and immune monitoring in clinical trials.
Sarah Missel holds a State Exam in Pharmacy and a PhD in Pharmacology/Immunology/Virology from LMU and Helmholtz Centre Munich.